Skip to main content

Table 1 Baseline characteristics of eligible studies

From: The predictive value of lncRNA MIR31HG expression on clinical outcomes in patients with solid malignant tumors

Authors Publication year Country Cancer type Sample size Follow-up months Detection method Clinical outcomes Analysis method NOS
Chen et al. [27] 2017 China Cervical cancer 120 60 qRT-PCR OS Multivariate 7
Ding et al. [18] 2015 China CRC 48 qRT-PCR Multivariate 6
Eideet al. [16] 2019 Norway CRC 1265 60 qRT-PCR RFS Multivariate 7
He et al. [25] 2016 China Bladder cancer 55 qRT-PCR Multivariate 6
Li et al. [31] 2018 China CRC 157 100 qRT-PCR OS, DFS Multivariate 7
Ni et al. [28] 2016 China VSCC 16 qRT-PCR Multivariate 6
Nie et al. [24] 2016 China Gastric cancer 42 40 qRT-PCR OS Multivariate 6
Qin et al. [22] 2018 China LUAD 112 85 qRT-PCR OS Multivariate 7
Ren , et al. [30] 2017 China ESCC 185 60 qRT-PCR OS Multivariate 6
Shih et al. [4] 2017 China OSCC 42 40 RNA-seq OS, RFS Multivariate 7
Sun et al. [29] 2018 China ESCC 53 qRT-PCR Multivariate 6
Sun et al. [14] 2019 China Osteosarcoma 40 qRT-PCR Multivariate 6
Wang et al. [35] 2018 China LSCC 60 85 qRT-PCR OS, RFS Multivariate 7
Wu et al. [40] 2019 China NSCLC 50 85 qRT-PCR OS Multivariate 8
Yan et al. [5] 2018 China HCC 42 25 qRT-PCR OS Multivariate 7
Yang et al. [32] 2016 China CRC 178 70 qRT-PCR OS, DFS Multivariate 7
Zheng et al. [2] 2019 China NSCLC 88 50 qRT-PCR OS Multivariate 8
  1. CRC colorectal cancer, DFS disease-free survival, ESCC esophageal squamous cell carcinoma, HCC hepatocellular carcinoma, LSCC laryngeal squamous cell cancer, LUAD lung adenocarcinoma, NOS Newcastle-Ottawa Scale, NSCLC Non–small cell lung cancer, OS overall survival, OSCC oral squamous cell carcinoma, qRT-PCR real-time quantitative reverse transcription polymerase chain reaction, RFS relapse-free survival, VSCC vulvar squamous cell carcinoma